ID: ALA2311988

Max Phase: Preclinical

Molecular Formula: C17H18N2O3S

Molecular Weight: 330.41

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NCCOc1ccc2sc3ccc(OCCN)cc3c(=O)c2c1

Standard InChI:  InChI=1S/C17H18N2O3S/c18-5-7-21-11-1-3-15-13(9-11)17(20)14-10-12(22-8-6-19)2-4-16(14)23-15/h1-4,9-10H,5-8,18-19H2

Standard InChI Key:  HMGFUDREZLTTEO-UHFFFAOYSA-N

Associated Targets(Human)

Endoribonuclease Dicer 19 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 330.41Molecular Weight (Monoisotopic): 330.1038AlogP: 2.09#Rotatable Bonds: 6
Polar Surface Area: 87.57Molecular Species: BASEHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.38CX LogP: 1.74CX LogD: -1.60
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.68Np Likeness Score: -0.43

References

1. Murata A, Fukuzumi T, Umemoto S, Nakatani K..  (2013)  Xanthone derivatives as potential inhibitors of miRNA processing by human Dicer: targeting secondary structures of pre-miRNA by small molecules.,  23  (1): [PMID:23164709] [10.1016/j.bmcl.2012.10.108]

Source